S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Cell Therapeutics Reports First Quarter 2013 Financial Results (2013/5/2)|
|Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013 (2013/4/24)|
|Cell Therapeutics to Present at Upcoming Investor Conferences (2013/5/15)|
|Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference (2013/3/11)|
|Cell Therapeutics Secures $15 Million Loan Financing Agreement (2013/3/28)|
|Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) (2013/4/10)|
|German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes Dossier Evaluation within Early Benefit Assessment Process of PIXUVRI® (pixantrone) (2013/3/1)|
|Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology (2013/3/4)|
|BrainStorm to Present at the 8th Annual New York Stem Cell Summit (2013/2/13)|
|Rasheda Ali on National and Local News: BrainStorm’s ALS Clinical Trial Results Exceeded Expectations (2013/2/27)|
Click above to view more mutual fund data and stats for ctic - Cell Therapeutics, Inc..